Cargando…

Robust Neutralizing Antibody Levels Detected after Either SARS-CoV-2 Vaccination or One Year after Infection

Humoral immunity after infection or after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been attributed a key part in mitigating the further transmission of the virus. In this study, we used a commercial anti-Spike immunoglobulin G (S-IgG) assay and developed a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glöckner, Stefan, Hornung, Franziska, Baier, Michael, Weis, Sebastian, Pletz, Mathias W., Deinhardt-Emmer, Stefanie, Löffler, Bettina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537517/ https://www.ncbi.nlm.nih.gov/pubmed/34696428 http://dx.doi.org/10.3390/v13102003

Ejemplares similares

The Inflammatory Profile of Obesity and the Role on Pulmonary Bacterial and Viral Infections
por: Hornung, Franziska, et al.
Publicado: (2021)

SARS-CoV-2 Testing of Emergency Department Patients Using cobas(®) Liat(®) and eazyplex(®) Rapid Molecular Assays
por: Egerer, Renate, et al.
Publicado: (2023)

Influenza Virus-Induced Paracrine Cellular Senescence of the Lung Contributes to Enhanced Viral Load
por: Schulz, Luise, et al.
Publicado: (2023)

Raman spectroscopic cellomics for the detection of SARS‐CoV‐2‐associated neutrophil activation after TNF‐α stimulation
por: Pistiki, Aikaterini, et al.
Publicado: (2022)

Staphylococcus aureus Pneumonia: Preceding Influenza Infection Paves the Way for Low-Virulent Strains
por: Deinhardt-Emmer, Stefanie, et al.
Publicado: (2019)

Respiratory Infections in the Aging Lung: Implications for Diagnosis, Therapy, and Prevention
por: Häder, Antje, et al.
Publicado: (2023)

Persistent humoral and CD4(+) T(H) cell immunity after mild SARS-COV-2 infection—The CoNAN long-term study
por: Schnizer, Clara, et al.
Publicado: (2023)

Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak—the CoNAN study
por: Weis, Sebastian, et al.
Publicado: (2021)

Newborns’ passive humoral SARS-CoV-2 immunity following heterologous vaccination of the mother during pregnancy
por: Gloeckner, Stefan, et al.
Publicado: (2022)

Neutralization of the Staphylococcus aureus Panton-Valentine leukocidin by African and Caucasian sera
por: Grebe, Tobias, et al.
Publicado: (2022)

Thoracic adipose tissue contributes to severe virus infection of the lung
por: Hornung, Franziska, et al.
Publicado: (2023)

A novel SARS-CoV-2 IgG line-blot for evaluating discrepant IgG test results – Observations in pre-pandemic and follow-up samples of five patients
por: Steiner, Andrea, et al.
Publicado: (2021)

SARS-CoV-2 Causes Severe Epithelial Inflammation and Barrier Dysfunction
por: Deinhardt-Emmer, Stefanie, et al.
Publicado: (2021)

Management of Staphylococcus aureus Bloodstream Infections
por: Kimmig, Aurelia, et al.
Publicado: (2021)

Simple, Fast and Convenient Magnetic Bead-Based Sample Preparation for Detecting Viruses via Raman-Spectroscopy
por: Pahlow, Susanne, et al.
Publicado: (2023)

First Time Isolation of Mycobacterium hassiacum From a Respiratory Sample
por: Deinhardt-Emmer, Stefanie, et al.
Publicado: (2018)

Persistent T-Cell Reactivity in a Seronegative Patient after SARS-CoV-2 Infection and One Vaccination
por: Andreas, Nico, et al.
Publicado: (2022)

D,L-Lysine-Acetylsalicylate + Glycine (LASAG) Reduces SARS-CoV-2 Replication and Shows an Additive Effect with Remdesivir
por: Jungwirth, Johannes, et al.
Publicado: (2022)

The epidemiology of bloodstream infections and antimicrobial susceptibility patterns in Thuringia, Germany: a five-year prospective, state-wide surveillance study (AlertsNet)
por: Schöneweck, Franziska, et al.
Publicado: (2021)

Clinical S. aureus Isolates Vary in Their Virulence to Promote Adaptation to the Host
por: Tuchscherr, Lorena, et al.
Publicado: (2019)

Staphylococcus aureus Lung Infection Results in Down-Regulation of Surfactant Protein-A Mainly Caused by Pro-Inflammatory Macrophages
por: Schicke, Elisabeth, et al.
Publicado: (2020)

Ruling out COVID-19 by chest CT at emergency admission when prevalence is low: the prospective, observational SCOUT study
por: Teichgräber, Ulf, et al.
Publicado: (2021)

Inhibition of Phosphatidylinositol 3-Kinase by Pictilisib Blocks Influenza Virus Propagation in Cells and in Lungs of Infected Mice
por: Deinhardt-Emmer, Stefanie, et al.
Publicado: (2021)

High prevalence of long-term olfactory dysfunction confirmed by olfactory testing after a community COVID-19 outbreak
por: Gudziol, Hilmar, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on influenza and respiratory syncytial virus antibody titres in the community: a prospective cohort study in Neustadt, Thuringia, Germany
por: Pletz, Mathias W., et al.
Publicado: (2022)

The Transmission of SARS-CoV-2 Infection on the Ocular Surface and Prevention Strategies
por: Kitazawa, Koji, et al.
Publicado: (2021)

Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies
por: Zhou, Dongyan, et al.
Publicado: (2021)

Effect of Automated Telephone Infectious Disease Consultations to Nonacademic Hospitals on 30-Day Mortality Among Patients With Staphylococcus aureus Bacteremia: The SUPPORT Cluster Randomized Clinical Trial
por: Weis, Sebastian, et al.
Publicado: (2022)

Robust induction of neutralizing antibodies against the SARS‐CoV‐2 Delta variant after homologous Spikevax or heterologous Vaxzevria‐Spikevax vaccination
por: Hammerschmidt, Swantje I., et al.
Publicado: (2022)

Prospective surveillance study in a 1,400‐bed university hospital: COVID‐19 exposure at home was the main risk factor for SARS‐CoV‐2 point seroprevalence among hospital staff
por: Bahrs, Christina, et al.
Publicado: (2021)

Non-patient-related SARS-CoV-2 exposure from colleagues and household members poses the highest infection risk for hospital employees in a German university hospital: follow-up of the prospective Co-HCW seroprevalence study
por: Bahrs, Christina, et al.
Publicado: (2023)

Introduction of mandatory masking in health care and community: experience from Jena, Germany
por: Pletz, Mathias W., et al.
Publicado: (2023)

Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants
por: Bates, Timothy A., et al.
Publicado: (2022)

Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage
por: Deinhardt-Emmer, Stefanie, et al.
Publicado: (2021)

Neutralizing Antibodies after Infection with Dengue 1 Virus
por: Guzman, Maria G., et al.
Publicado: (2007)

Safety and immune responses after intradermal application of Porcilis PRRS in either the neck or the perianal region
por: Stadler, Julia, et al.
Publicado: (2018)

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
por: Wajnberg, Ania, et al.
Publicado: (2020)

Neutralizing antibody responses 300 days after SARS‐CoV‐2 infection and induction of high antibody titers after vaccination
por: Urlaub, Doris, et al.
Publicado: (2022)

Near-Neutrality, Robustness, and Epigenetics
por: Ohta, Tomoko
Publicado: (2011)

From one to the other: responding to Ebola cases on either side of the line
por: Merrill, Rebecca Day, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6sa6h90sqjtido38fj2etnh4jg